Compare NALWA SONS INV with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NALWA SONS INV vs INDOCO REMEDIES - Comparison Results

NALWA SONS INV     Change

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NALWA SONS INV INDOCO REMEDIES NALWA SONS INV/
INDOCO REMEDIES
 
P/E (TTM) x 13.4 114.0 11.7% View Chart
P/BV x 1.1 1.9 55.2% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 NALWA SONS INV   INDOCO REMEDIES
EQUITY SHARE DATA
    NALWA SONS INV
Mar-18
INDOCO REMEDIES
Mar-18
NALWA SONS INV/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,511317 476.1%   
Low Rs820178 460.5%   
Sales per share (Unadj.) Rs70.4113.1 62.3%  
Earnings per share (Unadj.) Rs16.54.5 369.4%  
Cash flow per share (Unadj.) Rs16.511.8 139.6%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs720.073.2 983.0%  
Shares outstanding (eoy) m5.1492.15 5.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x16.62.2 755.7%   
Avg P/E ratio x70.655.5 127.4%  
P/CF ratio (eoy) x70.621.0 336.9%  
Price / Book Value ratio x1.63.4 47.9%  
Dividend payout %022.4 0.0%   
Avg Mkt Cap Rs m5,99122,830 26.2%   
No. of employees `000NA5.5 0.1%   
Total wages/salary Rs m92,209 0.4%   
Avg. sales/employee Rs Th90,450.01,910.1 4,735.4%   
Avg. wages/employee Rs Th2,125.0405.0 524.7%   
Avg. net profit/employee Rs Th21,200.075.5 28,096.7%   
INCOME DATA
Net Sales Rs m36210,419 3.5%  
Other income Rs m147 2.3%   
Total revenues Rs m36310,466 3.5%   
Gross profit Rs m1041,349 7.7%  
Depreciation Rs m0677 0.0%   
Interest Rs m0235 0.1%   
Profit before tax Rs m105484 21.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2072 28.0%   
Profit after tax Rs m85412 20.6%  
Gross profit margin %28.812.9 222.6%  
Effective tax rate %19.315.0 129.1%   
Net profit margin %23.44.0 593.3%  
BALANCE SHEET DATA
Current assets Rs m1,2765,373 23.8%   
Current liabilities Rs m1194,157 2.9%   
Net working cap to sales %319.811.7 2,739.9%  
Current ratio x10.71.3 827.4%  
Inventory Days Days2068 29.3%  
Debtors Days Days2673 35.1%  
Net fixed assets Rs m06,244 0.0%   
Share capital Rs m51184 27.9%   
"Free" reserves Rs m3,6506,566 55.6%   
Net worth Rs m3,7016,750 54.8%   
Long term debt Rs m3271,233 26.5%   
Total assets Rs m4,42712,363 35.8%  
Interest coverage x351.33.1 11,486.4%   
Debt to equity ratio x0.10.2 48.3%  
Sales to assets ratio x0.10.8 9.7%   
Return on assets %1.95.2 36.8%  
Return on equity %2.36.1 37.6%  
Return on capital %2.69.0 29.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m2241,227 18.3%  
From Investments Rs m-129-1,360 9.5%  
From Financial Activity Rs m2-388 -0.5%  
Net Cashflow Rs m97-521 -18.6%  

Share Holding

Indian Promoters % 55.4 59.2 93.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 0.6 12.5 4.8%  
FIIs % 4.2 6.0 70.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 22.4 176.8%  
Shareholders   23,884 12,805 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NALWA SONS INV With:   FINOLEX INDUSTRIES  EDELWEISS FINANCIAL  WONDERLA HOLIDAYS  TVS SRICHAKRA  ADANI PORTS & SEZ  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

NALWA SONS INV Announces Quarterly Results (3QFY19); Net Profit Up 41.5% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, NALWA SONS INV has posted a net profit of Rs 11 m (up 41.5% YoY). Sales on the other hand came in at Rs 17 m (up 20.1% YoY). Read on for a complete analysis of NALWA SONS INV's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NALWA SONS INV SHARE PRICE


Oct 15, 2019 (Close)

TRACK NALWA SONS INV

  • Track your investment in NALWA SONS INV with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NALWA SONS INV

NALWA SONS INV 8-QTR ANALYSIS

COMPARE NALWA SONS INV WITH

MARKET STATS